Evercore ISI analyst Vijay Kumar added Boston Scientific to the firm’s "Tactical Outperform" list as the firm made a number of changes to its lists as part of its Q1 earnings preview for the MedTech, Life Science Tools and Diagnostics group. The firm has an Outperform rating and $54 price target on Boston Scientific shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BSX:
- Boston Scientific price target raised to $60 from $54 at Citi
- Boston Scientific enters strategic partnership with Scivita Medical in China
- Boston Scientific initiated with a Buy at UBS
- TD Cowen medical devices analyst to hold analyst/industry conference call
- Wells downgrades Edwards Lifesciences with Medtronic gaining share